Journal Mobile Options
Table of Contents
Vol. 130, No. 4, 2013
Issue release date: November 2013
Acta Haematol 2013;130:288-290

Acute Hemolytic Anemia in Glucose-6-Phosphate Dehydrogenase Deficiency Complicated by Ginkgo biloba

Lai S.-W. · Chen J.-H. · Kao W.-Y.
aDivision of Hematology-Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, and bDivision of Hematology-Oncology, Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan, ROC

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


We report on a patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency who developed acute hemolytic anemia after having received an injection of Ginkgo biloba for dementia prophylaxis without medical advice. She suddenly developed general malaise, generalized yellowish skin color, and tea-colored urine. Intravenous fluid infusion and cessation of G. biloba quickly relieved her clinical symptoms. To the best of our knowledge, this is the first case report of G. biloba-induced acute hemolytic anemia in vivo. © 2013 S. Karger AG, Basel

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Bent S, Goldberg H, Padula A, Avins AL: Spontaneous bleeding associated with Ginkgo biloba: a case report and systematic review of the literature. J Gen Intern Med 2005;20:657-661.
  2. Rotblatt M, Ziment I: Evidence-Based Herbal Medicine. Philadelphia, Hanley & Belfus, 2002.
  3. Pawlikowska-Pawlega B, Gruszecki WI, Misiak LE, Gawron A: The study of the quercetin action on human erythrocyte membranes. Biochem Pharmacol 2003;66:605-612.
  4. Robaszkiewicz A, Balcerczyk A, Bartosz G: Antioxidative and prooxidative effects of quercetin on A549 cells. Cell Biol Int 2007;31:1245-1250.
  5. Shao ZH, Vanden Hoek TL, Xie J, Wojcik K, Chan KC, Li CQ, Hamann K, Qin Y, Schumacker PT, Becker LB, Yuan CS: Grape seed proanthocyanidins induce pro-oxidant toxicity in cardiomyocytes. Cardiovasc Toxicol 2003;3:331-339.
  6. Galati G, Sabzevari O, Wilson JX, O'Brien PJ: Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology 2002;177:91-104.
  7. He J, Lin J, Li J, Zhang JH, Sun XM, Zeng CM: Dual effects of Ginkgo biloba leaf extract on human red blood cells. Basic Clin Pharmacol Toxicol 2009;104:138-144.
  8. Kessler M, Ubeaud G, Jung L: Anti- and pro-oxidant activity of rutin and quercetin derivatives. J Pharm Pharmacol 2003;55:131-142.
  9. Sahu SC, Gray GC: Pro-oxidant activity of flavonoids: effects on glutathione and glutathione S-transferase in isolated rat liver nuclei. Cancer Lett 1996;104:193-196.
  10. Laughton MJ, Halliwell B, Evans PJ, Hoult JR: Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA. Biochem Pharmacol 1989;38:2859-2865.
  11. Yen GC, Duh PD, Tsai HL, Huang SL: Pro-oxidative properties of flavonoids in human lymphocytes. Biosci Biotechnol Biochem 2003;67:1215-1222.
  12. Cappellini MD, Fiorelli G: Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008;371:64-74.
  13. Youngster I, Arcavi L, Schechmaster R, Akayzen Y, Popliski H, Shimonov J, Beig S, Berkovitch M: Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review. Drug Saf 2010;33:713-726.
  14. Nang Kuang Pharmaceutical Co., Ltd. (accessed July 28, 2012).

Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00